[Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology]. 1992

T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
Department of Obstetrics and Gynecology, School of Medicine, Yamagata University.

The efficacy and safety of imipenem/cilastatin sodium (IPM/CS) were studied in patients with obstetric and gynecologic infections and in those given the drug as prophylaxis against postoperative infections. The following results were obtained: 1. Efficacy rates were 96.0% (48/50) in patients with obstetric and gynecologic infections and 100% (28/28) in those with urinary tract or other infections. The overall efficacy rate was 97.4% (76/78). Bacteriologically, 30 organisms were isolated from 28 patients. The eradication rate was 95.2% (20/21) and the efficacy rate was 96.4% (27/28). 2. Changes in blood elastase before and after treatment were compared with those in CRP, WBC, and ESR in the patients with obstetric and gynecologic infections. The changes in elastase were similar to those in CRP. 3. The efficacy rate was 98.0% (48/49) in the patients given prophylaxis against postoperative obstetric and gynecologic infections. 4. An adverse reaction was observed in only one patient (diarrhea), and abnormal laboratory findings were noted in 2 patients (elevation of GOT and GPT). These results indicate that IPM/CS is very useful for the treatment of obstetric and gynecologic infections.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
June 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
May 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
June 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
June 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
May 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
June 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
June 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
May 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
June 1986, The Japanese journal of antibiotics,
T Chimura, and M Banzai, and N Nara, and S Kawachiya, and T Ogawa, and R Miyata, and K Yamazaki, and S Aoyama, and M Matsuo, and Y Yokoyama
May 1986, The Japanese journal of antibiotics,
Copied contents to your clipboard!